COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa

Andrea C. Carcelen, Christine Prosperi, Simon Mutembo, Gershom Chongwe, Francis D. Mwansa, Phillimon Ndubani, Edgar Simulundu, Innocent Chilumba, Gloria Musukwa, Philip E Thuma, Kelvin Kapungu, Mutinta Hamahuwa, Irene Mutale, Amy Winter, William J. Moss, Shaun A. Truelove

Research output: Contribution to journalArticlepeer-review

Abstract

With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalHuman Vaccines and Immunotherapeutics
Volume18
Issue number1
DOIs
StatePublished - 2022

Keywords

  • COVID-19
  • Zambia
  • vaccine
  • vaccine acceptance
  • vaccine hesitancy
  • vaccine safety

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pharmacology
  • Immunology

Fingerprint

Dive into the research topics of 'COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa'. Together they form a unique fingerprint.

Cite this